With growing scrutiny of the role PBMs play in the pharmaceutical supply chain, we dive into the FTC’s recent administrative complaint...

Based on our own qualitative primary research conducted with payers, we have an idea on what is keeping them up at night.

When informing a payer customer about a complicated new product, how do you know what will matter? And how do you get and keep them engaged?

The IRA reforms on prescription drug pricing and coverage is definitely on payers' radar. See what else our research uncovered ...